PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Recruiting Observational Study
NAFLD - Nonalcoholic Fatty Liver Disease Diabetes Obesity Metabolic Syndrome Cirrhosis Liver Cancer NASH - Nonalcoholic Steatohepatitis HCC - Hepatocellular Carcinoma Fatty Liver
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, IBD (inflammatory bowel disease), dyslipidemia) without NAFLD in o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Clinical phenotype of NAFLD (simple steatosis, NASH, metabolic cirrhosis, NAFLD-HCC) based on any of: * Liver biopsy providing histological evidence of NAFLD or, * Biochemical and/or radiological findings consistent with NAFLD * Average alcohol consumption ≤21/…
Contacts

LUCA MIELE, MD, PhD

+390631051

luca.miele@policlinicogemelli.it; luca.miele@unicatt.it

CONTACT